Skip to content

Cell Biology: Organelles, iPSC Technology & MRT

1. CELL ORGANELLES & MITOCHONDRIAL GENOMICS
Cue WordsNotes
Key Cellular Organelles
  • **Nucleus**: Houses the master double-stranded nuclear DNA template governing cellular operations.
  • **Ribosomes**: Protein-translation factories; key clinical antibiotic target sites.
  • **Lysosomes**: Waste-recycling centres; degradation failures drive neurodegenerative disease.
Mitochondrial DNA & Replacement Therapy
  • **mtDNA**: Mitochondria carry their own autonomous, circular DNA — 16,569 base pairs encoding 37 genes (~0.1% of total human genetic material), inherited entirely from the mother; mitochondrial disorders affect ~1 in 5,000 live births globally.
  • **Mitochondrial Replacement Therapy (MRT)**: A three-parent IVF technique preventing transmission of severe mitochondrial disease, via **Maternal Spindle Transfer (MST)** or **Pronuclear Transfer (PNT)**, substituting mutant maternal mitochondria with healthy donor mitochondria.
> **Summary**: Organelle-level dysfunction underlies major disease categories — antibiotic targeting at ribosomes, neurodegeneration from lysosomal failure, and maternally-inherited mitochondrial disorders — with MRT offering the only clinical route to prevent, rather than merely treat, mtDNA disease transmission.
2. STEM CELLS & PLURIPOTENT REPROGRAMMING (iPSC)
Cue WordsNotes
Stem Cell Potency Gradients
  • **Totipotency**: Forms an entire organism including extra-embryonic tissue (e.g., zygote).
  • **Pluripotency**: Differentiates into any of the three embryonic germ layers — endoderm, mesoderm, ectoderm (e.g., Embryonic Stem Cells).
  • **Multipotency**: Differentiates into a limited range of lineages (e.g., Hematopoietic Stem Cells).
Induced Pluripotent Stem Cells (iPSC)
  • Somatic adult cells (e.g., skin cells) are reprogrammed back to an embryonic pluripotent state using the **4 Yamanaka factors** (Oct3/4, Sox2, Klf4, c-Myc).
  • **Therapeutic Advantage**: iPSCs bypass the ethical concerns of destroying human blastocysts and eliminate immunological-rejection risk since patient-derived cells are used — the key reason iPSC research has outpaced embryonic stem-cell work in regenerative-medicine pipelines.
> **Summary**: The potency gradient from totipotent to multipotent defines a cell's therapeutic range, and Yamanaka-factor reprogramming of adult cells into iPSCs has effectively sidestepped both the ethical and immunological barriers that limited embryonic stem-cell therapy.
3. PROGRAMMED CELL DEATH, AUTOPHAGY & NATIONAL GUIDELINES
Cue WordsNotes
Apoptosis & Autophagy
  • **Apoptosis**: Controlled cellular self-destruction eliminating damaged or pre-cancerous cells; dysfunction drives uncontrolled tumour growth. A healthy adult replaces 50-70 billion cells daily via this process.
  • **Autophagy**: Cells digest their own damaged organelles via lysosomes to survive nutrient starvation and clear toxic proteins (Ohsumi, Nobel 2016).
  • **Hayflick Limit**: Normal somatic cells divide only 40-60 times before senescence, due to telomeric decay.
National Guidelines for Stem Cell Research 2017
  • Joint ICMR-DBT framework: Approved — Hematopoietic Stem Cell Transplantation (HSCT) for blood disorders (leukaemias, thalassemias); Prohibited — human germline gene editing, reproductive cloning, and commercial banking of unproven stem cells (cord tissue, placenta, deciduous teeth).
> **Summary**: India's regulatory stance draws a clean line between clinically validated, life-saving cell therapy (HSCT) and speculative or ethically fraught applications (germline editing, commercial cord-blood banking), while cellular-clock mechanisms like apoptosis, autophagy, and the Hayflick limit set the biological boundaries any such therapy must work within.
UPSC Mains PYQs
  • Stem Cells & Therapeutics: Explain the concept of stem cells and discuss their potential applications in regenerative medicine and therapeutic cloning. (10 Marks, 150 Words)
  • Mitochondrial Replacement Therapy: Discuss the science and ethical debate surrounding three-parent IVF (Mitochondrial Replacement Therapy) in preventing inherited genetic disease. (10 Marks, 150 Words)
  • India's Stem Cell Regulation: Critically examine the ICMR-DBT National Guidelines for Stem Cell Research 2017 in balancing therapeutic innovation with ethical safeguards. (10 Marks, 150 Words)
  • Cell theory: the cell is the basic structural and functional unit of life, capable of independent existence; all living organisms are made of cells and all cells arise from pre-existing cells (three defining features: cell/plasma membrane, cytoplasm, and genetic material -- DNA/RNA).
  • R.H. Whittaker's Five Kingdom classification (Monera, Protista, Fungi, Plantae, Animalia) distinguishes organisms by cell type (prokaryotic/eukaryotic), organisation, cell wall presence, mode of nutrition, and motility -- a standard comparative table for prelims-mains linkage in basic biology.
  • Eukaryotic vs prokaryotic cells differ fundamentally: eukaryotes (animal, plant, fungal, protist cells) have a membrane-bound nucleus and organelles, are larger (10-100 micrometers), and are usually multicellular; prokaryotes (bacteria, archaea) lack a membrane-bound nucleus (nucleoid region instead), are smaller, replicate their whole genome at once, and divide faster.
  • The cell membrane is explained by the fluid mosaic model (phospholipid bilayer with embedded/peripheral proteins), is selectively permeable, and mediates active transport (energy-dependent), passive transport (down gradient), and osmosis (water movement).
  • Mitochondria (the cell's "powerhouse," site of ATP formation via aerobic/oxidative respiration) and chloroplasts (site of photosynthesis, found only in plants) are both double membrane-bound organelles carrying their own small circular DNA -- structural evidence cited by the endosymbiotic theory that they originated as free-living prokaryotes engulfed by an ancestral eukaryotic cell.
  • Recently, a new nitrogen-fixing organelle called "Nitroplast" was discovered in the marine alga Braarudosphaera bigelowii; it meets all criteria to be classified as a distinct cell organelle and can perform nitrogen fixation inside the algal cell, extending the endosymbiotic-origin model of organelles beyond mitochondria and chloroplasts.
  • Human somatic cells are diploid (2n = 46 chromosomes, 23 pairs); gametes are haploid (n) and are produced via meiosis, which yields four haploid daughter cells and includes crossing over (genetic recombination) -- fertilisation (fusion of male and female gametes) restores the diploid zygote, whose organelles (mitochondria) come only from the mother even though nuclear DNA comes from both parents.
  • The Hayflick limit is the maximum number of times a normal (non-cancerous) cell population can divide before entering replicative senescence (cell cycle arrest); it is governed by progressive shortening of telomeres with each division.
  • Because mitochondrial DNA (mtDNA) is transmitted only from the mother, a defective maternal mitochondrion is passed to the zygote, causing mitochondrial diseases such as Leigh's disease; mitigation techniques -- pronuclear transfer and maternal spindle transfer (reconstructed-egg technology), both performed after/around fertilisation -- combine nuclear DNA from the biological mother and father with mitochondrial DNA from a healthy donor female, producing a child with genetic material from three parents, raising bioethical and regulatory questions relevant to UPSC ethics/S&T answers.
  • Genome (the entirety of an organism's genetic material) is distinct from a gene (the functional unit of inheritance that codes for a protein) -- a conceptual distinction frequently tested alongside the central dogma of molecular biology (DNA to RNA to protein).
  • Viruses are small obligate intracellular particles (visible only under electron microscopy) that hijack host cellular machinery (ribosomes, tRNA, enzymes) to replicate their genome and synthesise a protein coat; they are transmitted from infected to uninfected hosts but show no living properties (no independent metabolism/growth) outside a host cell.
  • The virus concept emerged from study of the Tobacco Mosaic Disease: the infectious agent passed through bacterial filters and could not be cultured in artificial media, distinguishing it from bacteria; a similarly filterable agent was described as 'an invisible microbe antagonistic to Dysentery bacteria', later termed a bacteriophage.
  • Viral structure: the capsid (protein coat) helps the virus enter the host cell, assists in assembly, and invokes the host immune response; it is built from capsomeres (structural sub-units), which in turn assemble from protomeres. Enveloped viruses additionally carry a lipid-carbohydrate-protein envelope acquired from the host cell membrane during replication.
  • Viral genome classification with examples: dsDNA -- Adenovirus (non-enveloped), Herpesvirus; ssDNA -- Parvovirus; dsRNA -- Reovirus; ssRNA -- Orthomyxovirus (influenza viruses); ssRNA with reverse transcriptase -- Retrovirus; dsDNA with reverse transcriptase -- Hepadnavirus (Hepatitis B virus).
  • Viroids were discovered in 1971 by T.O. Diener; they are smaller than viruses, consist only of free RNA with no protein coat, and have low molecular weight, yet can still cause plant disease.
  • Prions are infectious agents consisting solely of abnormally folded protein (no nucleic acid), similar in size to viruses; they cause disease by inducing normal proteins to misfold.
  • Innate immunity is non-specific and present at birth, built on four barriers -- physical (skin/mucus), physiological (stomach acid), cellular (WBCs, B-cells, T-cells) and cytokine-based -- as the body's first line of defence before the pathogen-specific adaptive response engages.
  • Acquired/adaptive immunity is pathogen-specific and works on the principle of immunological memory, producing a slower primary response on first exposure and a faster, stronger secondary response on re-exposure, carried out by B-lymphocytes (humoral immunity) and T-lymphocytes (cell-mediated immunity).
  • In adaptive immunity, antigen-presenting cells (APCs) capture pathogens and display fragments to T-cells; this activates two T-cell lineages -- CD4+ helper T-cells, which act as the 'command centre' coordinating the response, and CD8+ cytotoxic T-cells, which directly kill infected cells.
  • Helper T-cells license B-cells via the CD40L co-stimulatory signal to launch a full antibody response; the resulting B-cell-produced antibodies circulate in blood to neutralise pathogens (hence called the humoral immune response), while cytotoxic T-cells carry out cell-mediated killing of infected cells; both memory B-cells and memory T-cells are generated for faster future responses.
  • Autoimmunity arises when the adaptive immune system's self/non-self discrimination fails and it attacks the body's own cells instead of pathogens, resulting in autoimmune diseases such as rheumatoid arthritis.
  • Therapeutic cloning uses somatic cell nuclear transfer (SCNT) to create patient-matched embryonic stem cells for research purposes (regenerative medicine, tissue engineering, disease research, drug testing) rather than to produce a whole organism; its key advantage is no immune rejection, since the resulting cells are genetically identical to the patient, removing the need for immunosuppressive drugs.
  • Organ-on-chip technology creates miniature functional models of organs -- micro-scale systems designed to mimic the human body environment as human-relevant 3D culture models. They recreate human organs and disease conditions while simulating blood flow, oxygen delivery and nutrient transport, offering advantages for precision-therapeutics simulation and modelling complex organ-organ relationships.
  • Newer approaches complementing organ-on-chip technology include organoids (3D structures that mimic the function of a real organ), tumoroids (3D cell clusters that mimic tumour behaviour, referred to as 'aphroids' in the source), and bio-printing (3D printing of tissue structures).
  • Ovoid cells are a newly identified type of brain cell found to play a fundamental role in recognition memory, the process by which the brain differentiates between new and familiar objects and forms long-term memories.
  • Molecular motors are remarkable molecular machines within a cell that convert the chemical energy stored in the molecule ATP into mechanical work, powering processes such as intracellular transport and muscle contraction.
  • A chimera is a single organism composed of cells of more than one distinct genotype (genetic makeup). Natural chimerism occurs across the animal kingdom, including humans -- for instance, traces of a fetus's genetic material can be observed in a mother's tissues many years after childbirth, a phenomenon called micro-chimerism. Artificial chimeras can be created through stem-cell transplant or bone-marrow transplant.
  • Hematopoietic stem cells (HSCs) have the capacity to self-renew and the potential to differentiate into all of the mature blood cell types, forming the basis of bone-marrow and cord-blood transplants.